Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Angelo Rosolen"'
Autor:
Luke Whitesell
Publikováno v:
Pediatric Blood & Cancer. 61:1336-1336
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::851877fc1c97e96c89ecde3834ba6856
https://doi.org/10.1002/pbc.25021
https://doi.org/10.1002/pbc.25021
Autor:
Pillon, Marta, Di Tullio, Maria Teresa, Garaventa, Alberto, Cesaro, Simone, Putti, Maria Caterina, Favre, Claudio, Lippi, Alma, Surico, Gianmarco, Di Cataldo, Andrea, D'Amore, Emanuele, Zanesco, Luigi, Rosolen, Angelo
Publikováno v:
Cancer; July 2004, Vol. 101 Issue: 2 p385-394, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marta Pillon, Maria Teresa Di Tullio, Alberto Garaventa, Simone Cesaro, Maria Caterina Putti, Claudio Favre, Alma Lippi, Gianmarco Surico, Andrea Di Cataldo, Emanuele D'Amore, Luigi Zanesco, Angelo Rosolen
Publikováno v:
Cancer (0008543X); Jul2004, Vol. 101 Issue 2, p385-394, 10p
Autor:
Eva Landmann, Birgit Burkhardt, Martin Zimmermann, Ulrike Meyer, Wilhelm Woessmann, Wolfram Klapper, Grazyna Wrobel, Angelo Rosolen, Marta Pillon, Gabriele Escherich, Andishe Attarbaschi, Auke Beishuizen, Karin Mellgren, Robert Wynn, Richard Ratei, Adriana Plesa, Martin Schrappe, Alfred Reiter, Christophe Bergeron, Catherine Patte, Yves Bertrand
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
In the European Intergroup EURO-LB02 trial, children and adolescents with lymphoblastic lymphoma underwent the non-Hodgkin lymphoma Berlin-Frankfurt-Münster protocol without prophylactic cranial radiotherapy. The primary aims of this trial were to t
Externí odkaz:
https://doaj.org/article/e8f212a9533540e381f2de12991b6a3f
Autor:
Federica Lovisa, Giorgio Cozza, Andrea Cristiani, Alberto Cuzzolin, Alessandro Albiero, Lara Mussolin, Marta Pillon, Stefano Moro, Giuseppe Basso, Angelo Rosolen, Paolo Bonvini
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0121378 (2015)
ALK inhibitor crizotinib has shown potent antitumor activity in children with refractory Anaplastic Large Cell Lymphoma (ALCL) and the opportunity to include ALK inhibitors in first-line therapies is oncoming. However, recent studies suggest that cri
Externí odkaz:
https://doaj.org/article/62e7c40e526442db9bcdff1be1cc6d88
Autor:
Lucia Tombolan, Matteo Zampini, Silvia Casara, Elena Boldrin, Angelica Zin, Gianni Bisogno, Angelo Rosolen, Cristiano De Pittà, Gerolamo Lanfranchi
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0125171 (2015)
Rhabdomyosarcomas (RMS) are rare but very aggressive childhood tumors that arise as a consequence of a regulatory disruption in the growth and differentiation pathways of myogenic precursor cells. According to morphological criteria, there are two ma
Externí odkaz:
https://doaj.org/article/8d216a766c53403fa265dfec0e42f6ae
Autor:
Maria De Salvo, Lavinia Raimondi, Serena Vella, Laura Adesso, Roberta Ciarapica, Federica Verginelli, Antonio Pannuti, Arianna Citti, Renata Boldrini, Giuseppe M Milano, Antonella Cacchione, Andrea Ferrari, Paola Collini, Angelo Rosolen, Gianni Bisogno, Rita Alaggio, Alessandro Inserra, Mattia Locatelli, Stefano Stifani, Isabella Screpanti, Lucio Miele, Franco Locatelli, Rossella Rota
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96238 (2014)
Rhabdomyosarcoma (RMS) is a pediatric myogenic-derived soft tissue sarcoma that includes two major histopathological subtypes: embryonal and alveolar. The majority of alveolar RMS expresses PAX3-FOXO1 fusion oncoprotein, associated with the worst pro
Externí odkaz:
https://doaj.org/article/041f3cb645cb418c9d123648054ee156
Autor:
Ilske Oschlies, Birgit Burkhardt, Itziar Salaverria, Andreas Rosenwald, Emanuele S.G. d’Amore, Monika Szczepanowski, Karoline Koch, Martin L. Hansmann, Harald Stein, Peter Möller, Alfred Reiter, Martin Zimmermann, Angelo Rosolen, Reiner Siebert, Elaine S. Jaffe, Wolfram Klapper
Publikováno v:
Haematologica, Vol 96, Iss 2 (2011)
Background Primary mediastinal large B-cell lymphoma is a rare lymphoma accounting for no more than 3% of all B-cell lymphomas in children and adolescents. However, patients in this young age group with this lymphoma have the shortest event-free surv
Externí odkaz:
https://doaj.org/article/3cd0dec745364399aa81bff4817d2360
Autor:
Paolo Bonvini, Elisa Zorzi, Lara Mussolin, Giovanni Monaco, Martina Pigazzi, Giuseppe Basso, Angelo Rosolen
Publikováno v:
Haematologica, Vol 94, Iss 7 (2009)
Background The loss of cell cycle regulation due to abnormal function of cyclin-dependent kinases (cdk) occurs in tumors and leads to genetic instability of chemotherapy-resistant cells. In this study, we investigated the effect of the cdk inhibitor
Externí odkaz:
https://doaj.org/article/997a6be040634cb79e8bc3642b1f6b5b